SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Twist Bioscience (TWST) stock came under pressure after Senior Vice President of Human Resources Paula Green sold more than 39,400 shares for nearly US$2.1 million, following a strong year to date ...
Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of ...
SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)-- Twist Bioscience Corporation (TWST) (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...
Hosted on MSN
Twist Bioscience outlines 13–15.5% revenue growth target for 2026 as AI-driven orders accelerate
CEO Emily Leproust highlighted a record quarter with $99 million in revenue and 17% year-over-year growth, noting "our 11th quarter of consecutive growth." She stated, "For the year, we reported ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...
1mon
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp ...
Twist Bioscience (NASDAQ:TWST) is gearing up to announce its quarterly earnings on Monday, 2026-02-02. Here's a quick overview of what investors should know before the release. Analysts are estimating ...
Twist Bioscience (NasdaqGS:TWST) entered a licensing agreement with Invenra Inc. to co-exclusively provide Invenra's B-Body bispecific antibody platform. The deal broadens Twist's antibody discovery ...
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equities continue to ...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has entered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results